Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tight junction proteins are a diverse group of molecules that form the tight junctions—specialized multiprotein complexes located at the apical region between adjacent epithelial or endothelial cells. These proteins create a selective barrier that regulates the passage of ions, water, and solutes through the paracellular pathway. The main families include claudins, occludin, tricellulin, marvelD3 (all transmembrane proteins), as well as scaffolding proteins like zonula occludens 1 (ZO‑1). Tight junctions are essential for maintaining cell polarity by separating apical and basolateral membrane domains and play key roles in tissue homeostasis by controlling permeability. They also participate in signaling pathways influencing cell differentiation and proliferation. Disruption or dysregulation of tight junction proteins is implicated in various diseases such as cancer and inflammatory conditions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tight junction protein (TJ protein).